Wednesday, February 28, 2024

Peptic Ulcer Drugs Market Outlook, Global Industry Share, Growth, Drivers, Emerging Technologies, and Forecast

Market Summery:

Peptic Ulcer Drugs Market Size was valued at USD 4.2 billion in 2022 and to grow from USD 4.4 Billion in 2023 to USD 5.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.80% during the forecast period (2023 - 2030).

Market Highlights

The Peptic Ulcer Drugs Market, primarily focusing on stomach ulcer medication, is witnessing significant growth due to several factors. Stomach ulcers, also known as peptic ulcers, are painful sores that develop in the lining of the stomach, small intestine, or esophagus. The rising prevalence of gastrointestinal disorders, including peptic ulcers, is a key driving factor for the market growth. Factors such as stress, unhealthy lifestyle habits, and the widespread use of nonsteroidal anti-inflammatory drugs (NSAIDs) contribute to the increasing incidence of stomach ulcers, thereby fueling the demand for effective medications.

In response to this growing demand, pharmaceutical companies are actively developing innovative stomach ulcer medication to provide relief to patients. These medications aim to alleviate symptoms, promote ulcer healing, and prevent recurrence. Proton pump inhibitors (PPIs), histamine receptor antagonists (H2 blockers), and antibiotics are among the commonly prescribed drugs for stomach ulcers. Additionally, advancements in drug delivery technologies are enhancing the efficacy and safety profile of these medications, further propelling market expansion. Overall, the Peptic Ulcer Drugs Market, driven by the increasing prevalence of stomach ulcers and ongoing research and development efforts, is poised for substantial growth in the coming years, offering promising prospects for pharmaceutical companies and healthcare providers alike.

Competitive Dashboard

Daiichi Sankyo Company Limited,

Novartis AG,

Acetelion Ltd.,

Sanofi S.A.,

Boehringer Ingelheim,

Astra Zeneca plc,

Takeda Pharmaceuticals Company Limited,

Ranbaxy Laboratories Limited, Inc.,

Pfizer Inc.,

Eumedica Pharmaceuticals, and

Helicure AB,

are some of the key peptic ulcer drugs Companies in global market.

Segmental Analysis

The global peptic ulcer drugs market has been segmented on the basis of pharmacological class into proton pump inhibitors (PPIs), anti-histamines, H2 antagonists, antacids, antibiotics and others.

The market is segmented by clinical application into gastric ulcers, duodenal ulcer, and esophageal ulcer.

Regional Overview

Geographically, the global peptic ulcer market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

It is estimated that North America will lead the global demand for peptic ulcers, accounting for the highest share over the expected period. A increase in non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and the understanding of peptic ulcer treatment options are factors that are expected to boost the growth demand for peptic ulcer drugs in the North American region. North America 's market rise is due to an rise in the prevalence of stomach cancer in the country.

The second largest share of the demand for peptic ulcer drugs in Europe is partly due to the simple availability of effective treatment alternatives for peptic ulcers in the country.

During the forecast period, the Asia Pacific market is projected to develop at a higher growth rate. Because of the large population, growth in health consciousness and high prevalence of lifestyle-related diseases, stomach infections caused by H, it is the most lucrative market. Pylori, as well as cancer.

Related reports-

Hair Removal Devices

reusable auto injector

Europe Facial Injectable

Oncology drugs

Microspheres

For more information, Please Visit us @ Market Research Future

Medical Implants Market Growth Analysis, Projection, Industry Trends & Market Forecast

Medical Implants Market Synopsis:

The Medical Implant Market Size was valued at USD 45.9 Billion in 2022. The Medical Implant market industry is projected to grow from USD 49.66 Billion in 2023 to USD 93.29 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.20% during the forecast period (2023 - 2032).

The medical implants market has witnessed remarkable growth, particularly in the realm of hearing implants. These innovative devices cater to individuals with hearing impairments, offering a transformative solution to enhance their auditory experience. Hearing implants utilize cutting-edge technology to bypass damaged parts of the ear and directly stimulate the auditory nerve, enabling users to perceive sound more effectively. This technology has significantly improved the quality of life for millions of individuals worldwide, providing them with the opportunity to engage more fully in social interactions and daily activities. As the demand for hearing implants continues to rise, manufacturers are investing in research and development to further enhance the functionality and accessibility of these devices.

Moreover, advancements in hearing implant technology have expanded the market's reach beyond traditional cochlear implants to include bone conduction implants and middle ear implants. These alternatives cater to individuals with specific types of hearing loss, offering personalized solutions that align with their unique needs. The growing prevalence of hearing disorders, coupled with an aging population, has fueled the demand for hearing implants, driving market growth. Additionally, increased awareness about the benefits of early intervention for hearing loss has contributed to the expansion of this market segment. With ongoing technological advancements and a growing focus on patient-centric innovations, the future of the medical implants market, particularly in the realm of hearing implants, looks promising.

Market Segmentation:

By type, the global medical implants market is segmented into orthopedic implants, cardiac implants, spinal implants, dental implants, ophthalmic implants, cosmetic implants, and others. The cardiac implants segment is prognosticated to register a relatively higher CAGR of 7.63% over the forecast period.

By type of material, the medical implants market has been segmented into metallic material, ceramic material, polymers material, and others.

By end-users, the global medical implants market is segmented into hospitals & clinics, research laboratories, and others.

Competitive Dashboard:

The global medical implants companies are Johnson & Johnson Services, Inc. (U.S.), 3M (U.S.), Institut Straumann AG (Switzerland), Stryker Corporation (U.S.), Boston Scientific Corporation (U.S.), Medtronic (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), Smith & Nephew (U.K), Dentsply Sirona (U.S.).

Regional Insights:

By region, the global medical implants market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is the largest market for medical implants and is expected to flourish in the forthcoming years. The factors responsible for favouring the growth of the market in the region are increasing patient pool, accelerated investments in research, developed healthcare, advanced technologies, etc.

Europe holds the second spot in the global medical implants market due to exponential geriatric population, rising healthcare expenditure, increasing government support, etc. Asia Pacific is projected to be the fastest growing regional market over the assessment period. The presence of countries such as China and India are likely to favour the growth of the medical implants market in the region. Meanwhile, the Middle East & Africa region is poised to hold a comparatively lesser medical implants market share of the global market owing to limited development in the healthcare sector. However, economically strong countries such as Qatar and Kuwait are poised to aid market expansion in the foreseeable future.

Related Reports-

Europe Facial Injectable

Oncology drugs

Hair Removal Devices

reusable auto injector

Microspheres

For more information, Please Visit us @ Market Research Future

Healthcare Data Storage Market Industry Analysis, Trends, Demand, Growth, Opportunities and Forecast

Market Analysis

The global healthcare data storage market size is projected to touch a 15.30% CAGR between 2023-2032, as per the recent Market Research Future (MRFR) report. The Healthcare Data Storage Market is experiencing substantial growth driven by the increasing demand for efficient and secure medical data management solutions. As the healthcare industry continues to transition towards digitalization, the need for advanced storage systems to handle vast amounts of medical data becomes paramount. Medical data management, a critical aspect of this market, focuses on the organization, storage, and retrieval of patient information, diagnostic records, and other healthcare-related data.

In this dynamic landscape, healthcare organizations are adopting cutting-edge technologies to enhance medical data management capabilities. Cloud-based storage solutions, data encryption, and advanced analytics are becoming integral components in safeguarding sensitive medical information while ensuring accessibility and scalability. The Healthcare Data Storage Market is witnessing a surge in investments as stakeholders recognize the significance of robust and compliant data storage systems to streamline workflows, improve patient care, and facilitate medical research. As the industry strives to strike a balance between innovation and regulatory compliance, medical data management emerges as a key driver in shaping the future of healthcare data storage solutions.

Market Segmentation 

The global healthcare data storage market is thoroughly analyzed in the Market Research Future report, which delves into various segments such as end user, storage system, type, architecture, application, and solution.

Regarding solutions, the healthcare data storage market is categorized into hybrid data storage, cloud-based solutions, and on-premise solutions. Among these, the on-premise solutions are expected to take the lead throughout the forecast period.

In terms of applications, the healthcare data storage market is divided into operational analysis, financial analysis, and clinical analysis. Clinical analysis is further segmented into precision health, population health management, reporting and compliance, quality control, and clinical decision support. Financial analysis is also subdivided into risk adjustment and assessment, claim processing, revenue cycle management, and other financial aspects. Clinical analysis is anticipated to dominate the market during the forecast period, primarily due to the rising number of diagnostic centers, clinics, and hospitals.

The architecture segment of the healthcare data storage market includes block storage, object storage, and file storage. Object storage is projected to hold the largest market share during the forecast period.

In terms of storage type, the healthcare data storage market encompasses magnetic storage and flash & solid-state storage. Flash and solid-state storage are expected to be the dominant segment during the forecast period.

The storage system segment of the healthcare data storage market comprises direct-attached storage, network-attached storage, and storage area network. The storage area network is anticipated to lead the market during the forecast period.

Lastly, the end-user segment of the healthcare data storage market includes contract manufacturing organizations, clinical/contract research organizations, pharmaceuticals and biotechnology companies, hospitals and clinics, and others. Hospitals and clinics are projected to dominate this segment during the forecast period.

Key Players

Global healthcare data storage companies profiled in the report include Carestream Corporation (US), Nuance Communications, Inc (US), Western Digital (US), Hitachi (Japan), Pure Storage (US), Hewlett Packard Enterprise (HPE)(US), NetApp (US), IBM Corporation (US), Dell Inc. (US), and DataCore Software (US). Key players have incorporated several strategies to create a niche in the market, such as strategic alliances, mergers and acquisitions, collaborations, product developments, and others. 

Regional Analysis 

By region, the global healthcare data storage market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market during the forecast period for the use of innovative solutions by clinics and hospitals for maintaining patient data and the availability of the most up to date healthcare information technology solutions. 

The global healthcare data storage market in Europe will hold the second-largest share during the forecast period owing to the presence of several healthcare companies offering diagnostic and treatment products, thereby increasing the demand for IT solutions for healthcare data storage. Besides, the presence of a huge patient population suffering from arthritis, diabetes, and cancer is also boosting the market growth. 

The global healthcare data storage market in the APAC region is predicted to grow at the fastest pace over the forecast period for rapid technological developments and the presence of several developing countries, especially China, India, and Japan. 

The global healthcare data storage market in the MEA will have steady growth during the forecast period for growing technological advances and developing healthcare infrastructure. 

Related reports-

Europe Facial Injectable

Oncology drugs

Hair Removal Devices

reusable auto injector

Microspheres

For more information, Please Visit us @ Market Research Future

Capillary Blood Collection Devices Market Growth Analysis, Projection, Industry Trends & Market Forecast

Market Summery

Acknowledging the impressive growth records, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global Capillary Blood Collection Devices market size will register a staggering CAGR of 6.2% from 2022-2030, witnessing the accruals of approx. 790 Mn. USD by 2030.

The Capillary Blood Collection Devices Market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases and the growing demand for minimally invasive diagnostic procedures. Among the various devices in this market segment, capillary blood collection tubes play a pivotal role in the collection, storage, and transportation of blood samples. These tubes are designed to facilitate the collection of small blood volumes from capillaries, typically from a finger prick, making them particularly useful in settings where venous blood collection is challenging or impractical.

The demand for capillary blood collection tubes is fueled by their convenience, accuracy, and efficiency in point-of-care testing and remote healthcare settings. With advancements in technology, manufacturers are focusing on developing capillary blood collection tubes with improved features such as better compatibility with various analyzers, enhanced sample stability, and reduced risk of hemolysis. Additionally, the market is witnessing a surge in the adoption of capillary blood collection tubes in applications such as glucose monitoring, hemoglobin testing, and lipid profiling, further driving market growth. As healthcare systems continue to prioritize decentralized testing and remote patient monitoring, the Capillary Blood Collection Devices Market is expected to expand, with capillary blood collection tubes playing a crucial role in facilitating decentralized diagnostic testing and improving healthcare accessibility and efficiency.

Competitive Landscape of Capillary Blood Collection Devices Market:

The global market for capillary blood collection devices is characterized by intense competition and diversification, with major manufacturers operating on a global scale. These players are heavily investing in research and development, global expansion, advanced technologies, and product launches to gain a competitive edge in the market.

Key Players:

The market for capillary blood collection devices companies includes such as Danaher Corporation, Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Medtronic Plc., Novo Nordisk A S, Thermo Fisher Scientific Inc., Terumo Corporation, B. Braun Melsungen AG, HTL-STREFA S.A., Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio-One, Owen Mumford Ltd., Improve Medical, Nipro, Chengdu Rich Science Industry Co., Ltd., Weigao Group, Weihai Hongyu Medical Devices, and Medigard. MRFR has profiled these players and analyzed their strategies for maintaining a competitive position in the market.

Segments of Capillary Blood Collection Devices Market:

The analysis by MRFR is segmented into four key areas to facilitate the report and improve comprehension:

Materials: Including Glass, Plastic, and Stainless Steel, among others. Types of Devices: Encompassing Warming Devices, Blood Collecting Tubes & Collectors, and Lancets, among others. End-Users: Such as Hospitals, Clinics, Diagnostic Centers, Home Diagnostics, and Pathology Laboratories, among others. Regions: Covering North America, Europe, APAC, and Rest-of-the-World. Plastic is projected to dominate the materials segment, acquiring 42.3% of the market share, making it the largest share. This segment is expected to register a 10.4% CAGR during the period of 2017–2023.

The Blood Collecting Tubes and Collector segment is anticipated to hold the largest share based on types of devices, accounting for 48.4% of the market share over the review period.

The Lancets Segment is projected to grow at a CAGR of 10.4% between 2017–2023.

Regional Analysis of Capillary Blood Collection Devices Market:

North America leads the global capillary blood collection devices market, supported by established players and investments, holding the largest market share. Companies manufacturing these devices can provide customized solutions, and the region sees increased uptake of software solutions for healthcare administration, driving market growth.

Factors contributing to market growth include a rising number of patients with chronic diseases, demand for technologically advanced diagnosis and treatment, government support, and high per capita healthcare expenditures, with the market estimated to reach US$ 292.96 million by 2023.

Europe is the second-largest market for capillary blood collection devices globally, driven by technological advancements and increased adoption among healthcare providers, particularly in the UK, Germany, and France. Factors such as public and private funding for research and development, leading market players, and the prevalence of diabetes are expected to fuel market growth.

The Asia Pacific market is emerging as a promising market for capillary blood collection devices, driven by new diagnosis and treatment methods, increasing prevalence of chronic diseases like diabetes, and growing awareness about health management among the population. The APAC market is estimated to grow at a CAGR of 10.6% during 2017–2023.

The Middle East & Africa region is expected to experience a plateau in growth due to factors such as limited awareness, access, and availability of treatment facilities in the African market. However, the Middle East is expected to see steady growth due to its well-developed healthcare sector, particularly in countries like the UAE.

Related Reports-

Hair Removal Devices

reusable auto injector

Microspheres

Europe Facial Injectable

Oncology drugs

For more information, Please Visit us @ Market Research Future

Poultry Vaccines Market to Exhibit Paced Growth Owing to Robust Innovations in Healthcare Industry

Market Highlights

The Poultry Vaccines Market plays a pivotal role in the broader scope of poultry health management, serving as a cornerstone in disease prevention and overall flock wellbeing. Poultry health management encompasses a range of strategies aimed at safeguarding the health of poultry populations, from biosecurity measures to vaccination protocols. Within this framework, poultry vaccines serve as indispensable tools, offering targeted protection against various pathogens that threaten flock health. These vaccines are meticulously developed to address specific disease challenges prevalent in poultry farming, including but not limited to Newcastle disease, infectious bronchitis, and avian influenza. By incorporating vaccines into comprehensive health management programs, poultry producers can effectively mitigate disease risks, reduce mortality rates, and enhance overall productivity, thereby ensuring the sustainability of their operations.

The Poultry Vaccines Market Size was worth USD 1.8 billion in 2022 and is expected to reach USD 3.32 billion by 2032 at 7.05% CAGR during the forecast period 2023 to 2032.The growth of the Poultry Vaccines Market is intricately linked to advancements in poultry health management practices, driven by an increasing emphasis on preventive healthcare in the poultry industry. As stakeholders recognize the significance of proactive disease control measures, the demand for innovative vaccines tailored to address emerging disease threats continues to rise. Additionally, regulatory frameworks mandating the use of certain vaccines to maintain flock health further propel market expansion. Moreover, the adoption of advanced vaccination technologies, such as vector vaccines and recombinant vaccines, underscores a paradigm shift towards more efficacious and targeted disease management strategies. Overall, the Poultry Vaccines Market stands as a critical component of poultry health management, offering indispensable solutions to safeguard the welfare and productivity of poultry populations in an ever-evolving agricultural landscape.

Key Players

Some of the key Poultry Vaccines Companies are

Boehringer Ingelheim,

Elanco,

MSD & Co.,

Zoetis Inc,

Ceva Animal Health Inc.,

Phibro Animal Health Corporation,

Virbac,

Hipra,

Venkys,

Biovet, and

Anicon GmbH, and

Others.

Segmentation

The global Poultry Vaccines Market Report has been segmented based on diseases, technology, dosage form and region.

  • Based on disease, the market has been classified as infectious bronchitis, avian influenza, marek's disease, newcastle disease, and others. the market, by technology, has been segmented into toxoid vaccinesrecombinant vaccines, inactivated vaccines, live attenuated vaccines (lav), and others. based on dosage form, the market has been segmented into duct vaccines, liquid vaccines, and freeze-dried vaccines.
  • Based on technology, live attenuated vaccines segment is expected to hold the largest market share of the poultry vaccines market during the forecast period. Also, recombinant vaccines segment to register the fastest growth in the global poultry vaccines market during the forecast period.

Regional Analysis

The Poultry Vaccines Market Outlook is likely to dominate by Americas during the forecast period owing to the awareness about the prevention of animal-to-human transmission diseases, rising demand for safe animal food supply, and increasing investment in research and development for animal vaccines. Moreover, high expenditure spending and favorable reimbursement policy also fueling the growth of the market during forecast periods. The European market is expected to be the second-largest due to government support for research & development and improved animal husbandry practices. However, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to rising awareness and increase in the number of animal welfare programs. The market in the Middle East & Africa is likely to account for the smallest share of the global poultry vaccines market.

Related Reports-

Hair Removal Devices

reusable auto injector

Microspheres

Europe Facial Injectable

Oncology drugs

For more information, Please Visit us @ Market Research Future

Robot-Assisted Surgical Systems Market to Exhibit Paced Growth Owing to Robust Innovations in Healthcare Industry

Market Overview

It is projected that the global robot-assisted surgical system market size is projected to reach at a CAGR 16.5% During the forecast period 2023-2032. The Robot-Assisted Surgical Systems Market is witnessing rapid growth, driven by technological advancements and increased demand for minimally invasive procedures. These systems offer enhanced precision, dexterity, and control to surgeons, resulting in improved patient outcomes and shorter recovery times. Key players in the market are continuously investing in research and development to introduce innovative solutions, expanding the application areas of robot-assisted surgery. The market is characterized by intense competition, with companies focusing on strategic partnerships and acquisitions to strengthen their market presence. Factors such as rising healthcare expenditure and growing awareness about the benefits of robotic surgery are expected to fuel further market expansion.

Top of Form

The Robot-Assisted Surgical Systems market is witnessing a transformative surge, fueled by advancements in Automated Surgical Instruments and Robotic Surgery Technology. These cutting-edge innovations are revolutionizing the landscape of surgical procedures, offering unparalleled precision, efficiency, and patient outcomes. Automated Surgical Instruments, equipped with intelligent features and automation capabilities, are streamlining surgical workflows, reducing human error, and enhancing surgical precision. This technology integrates seamlessly with existing surgical systems, augmenting the capabilities of surgeons and healthcare professionals. As demand for minimally invasive procedures continues to rise, Automated Surgical Instruments play a pivotal role in enabling complex surgeries with smaller incisions, reduced trauma, and faster recovery times.

Global Robot-Assisted Surgical Systems Market: Segmental Analysis

The segmental analysis of the global robot-assisted surgical systems market has been conducted on the basis of end user, product, and application.

On the basis of end user, the market has been segmented into healthcare payers, healthcare providers and others. Based on product, the market has been segmented into rehabilitation robots, hospital and pharmacy robots, emergency response robotic systems, surgical robots and non-invasive radiosurgery robots. The rehabilitation robots segment covers prosthetics, therapeutic robots, robotic exoskeleton systems, orthotics and assistive robots. The hospital and pharmacy robots segment covers IV robots, cart transportation robots, pharmacy robots and telemedicine robots. The surgical robot segment covers laparoscopy robotic systems, robotic neurosurgical systems, and orthopedic surgical robots. Categories of laparoscopy robotics systems include Da Vinci robotic surgery system, Steerable Robotic Catheters, FreeHand endoscope holder system and Telelap ALF-X surgical system. Categories of robotic neurosurgical systems include NeuroMate surgical system, Renaissance surgical system and Pathfinder surgical system. Categories of orthopedic surgical robots include Robodoc surgical system, iBlock surgical system, MAKO RIO surgical system, Stanmore Sculptor surgical system and Navio PFS surgical system. On the basis of application, the market has been segmented into orthopedics robotic systems, special education, laparoscopy and neurology.

Global Robot-Assisted Surgical Systems Market: Competition Analysis

The Robot-Assisted Surgical Systems Companies are Renishaw Plc, Stryker Corporation (MAKO Surgical Corp.), Accuracy, Health Robotics S.R.L.,Auris Surgical Robotics, Inc. (Hansen Medical Inc.), Medtronic plc, Zimmer Biomet Holdings Inc., Verb Surgical,Titan Medical, Microbot Medical, Varian, Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Transenterix, KUKA AG, Medrobotics, Intuitive Surgical Inc, THINK Surgical Inc., and Mazor Robotics are among the key companies profiled in MRFR’s report.

Global Robot-Assisted Surgical Systems Market: Regional Analysis

The regional analysis of the market has been conducted across the Middle East and Africa (MEA), Asia Pacific (APAC), Europe, and the Americas. In MEA, the market has been assessed in GCC countries and Africa. In APAC, countries such as China, Japan, India, South Korea, Australia, among others are covered. In the report, the Europe market has been segmented into Western and Eastern Europe. In West Europe, countries such as Germany, France, Italy, Spain, and the UK were under the spotlight. The Americas market has been segmented into Latin America and North America. In North America, the U.S. and Canada are covered.

Related Reports-

reusable auto injector

Microspheres

Europe Facial Injectable

Hair Removal Devices

Oncology drugs

For more information, Please Visit us @ Market Research Future

Syringe and Needle Market Analysis by Regions, Types and Application & Segmentations

Market Overview-

The global syringe and needle market size is expected to grow USD 14.74 billion by 2032 at a CAGR of 5.90% and surpass its previous revenues over the forecast period of 2023–2032, as per a research report published by Market Research Future (MRFR). The syringe and needle market is a crucial component of the healthcare industry, facilitating precise medication administration and fluid extraction across various medical settings. Within this market, a notable segment gaining traction is insulin pen needles. As the prevalence of diabetes continues to rise globally, the demand for efficient insulin delivery systems has intensified. Insulin pen needles offer a convenient and less invasive method for diabetic patients to administer insulin compared to traditional syringes. This has led to a surge in the production and adoption of insulin pen needles by both healthcare providers and patients, driving growth in the syringe and needle market.

The emergence of insulin pen needles within the syringe and needle market is also influenced by advancements in technology and manufacturing processes. Manufacturers are continuously innovating to improve the design, functionality, and safety features of insulin pen needles, enhancing user experience and ensuring precise insulin dosage delivery. Additionally, the growing emphasis on patient comfort and adherence to treatment regimens has propelled the development of insulin pen needles with finer gauges and shorter lengths, minimizing pain and discomfort during injections. With these advancements and the increasing prevalence of diabetes worldwide, the insulin pen needle segment is expected to sustain its growth trajectory, contributing significantly to the overall expansion of the syringe and needle market.

Segmentation

The global syringes and needle market has been segmented based on type, therapeutic application, usability, and end-user. By type, the market has been segmented into Blood Collection, Intravenous, and Catheter. By therapeutic application, the market has been segmented into General Surgery and Diagnostic. By usability, the market has been segmented into disposable and reusable. By end user, the market has been segmented into Hospitals & Clinics and Home Care.

Competitive Landscape

Global Syringe and Needle Companies include

  • Braun Medical Inc.,
  • Terumo Corporation,
  • Albert David Ltd,
  • Covidien Plc,
  • Smiths Medical, and
  • Connecticut Hypodermics Inc.

Regional Analysis

The key markets of the global syringes and needle market include North America, Europe, Asia Pacific and the Middle East & Africa. North America accounts for the majority share of the global market owing to the prevalence of chronic diseases in the region coupled with increased R&D activities which induce the demand of the market. Additionally, the presence of a large customer base in the region also propels the market growth. Europe is the second largest market owing to increased R&D spending by pharmaceuticals and biotechnology sector in the region. Presence of a developed healthcare sector also supports the market growth in the region. Asia Pacific is expected to be the fastest growing market over the forecast period. The growth in the region would be favored by the prevalence of chronic diseases in the region which escalates the need for treatment and growing research and development in the field of life sciences in the region.  The Middle East & Africa region is expected to exhibit the least growth over the forecast period due to less expenditure on healthcare and limited growth of the healthcare sector in the region.

Related Reports-

Hair Removal Devices

Oncology drugs

reusable auto injector

Microspheres

Europe Facial Injectable

For more information, Please Visit us @ Market Research Future

Growing Adoption of Non-Invasive Tattoo Removal Techniques: Market Implications

Tattoo Removal Market: Overview and Trends The tattoo removal market is a dynamic and growing sector within the global aesthetics industry...